RT Journal Article
SR Electronic
T1 Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004419
DO 10.1136/jitc-2021-004419
VO 10
IS 4
A1 Tannir, Nizar M
A1 Cho, Daniel C
A1 Diab, Adi
A1 Sznol, Mario
A1 Bilen, Mehmet A
A1 Balar, Arjun V
A1 Grignani, Giovanni
A1 Puente, Erika
A1 Tang, Lily
A1 Chien, David
A1 Hoch, Ute
A1 Choudhury, Arkopal
A1 Yu, Danni
A1 Currie, Sue L
A1 Tagliaferri, Mary A
A1 Zalevsky, Jonathan
A1 Siefker-Radtke, Arlene O
A1 Hurwitz, Michael E
YR 2022
UL http://jitc.bmj.com/content/10/4/e004419.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.